{"public_id":"co_e8236166c61305a9ee565773968e5793","status":"active","merged_into_public_id":null,"resolved_public_id":"co_e8236166c61305a9ee565773968e5793","name":"intravenous methylprednisolone pulse therapy","description":"High-dose intravenous methylprednisolone administered in pulses as the initial treatment step.","aliases":["MP pulse therapy","methylprednisolone"],"types":["treatment"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":28529639,"title":"Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.","citation_count":31,"url":"https://sah.borca.ai/papers/28529639"}],"claims":[{"public_id":"cl_ed3d77d706abfdd1420613788e23cbba","text":"Complete recovery of dysthyroid optic neuropathy was achieved in a majority of patients using combination therapy with intravenous methylprednisolone pulse therapy and surgical decompression.","corpus_id":28529639,"url":"https://sah.borca.ai/claims/cl_ed3d77d706abfdd1420613788e23cbba"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_e8236166c61305a9ee565773968e5793","url":"https://sah.borca.ai/concepts/co_e8236166c61305a9ee565773968e5793"}